MDMA for Traumatic Brain Injury? Wesana Health And MAPS To Assess Drug’s Treatment Viability Sep 15, 2021
Numinus Announces Health Canada Approval of MAPS-Sponsored Open Label Study for MDMA-Assisted Therapy for PTSD Jul 12, 2021
What Is A Compassionate Access Trial? Numinus CSO & Co-Founder Stacey Wallin Has The Details Jun 7, 2021
